LAB FY 2014 Earnings — Standard BioTools Inc. Revenue & Financial Results | Market Cap Arena

LABStandard BioTools Inc.

$370M

FY 2014 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$116M+63.6% YoY

Gross Profit

$74M63.2% margin

Operating Income

-$52M-44.5% margin

Net Income

-$53M-45.4% margin

EPS (Diluted)

$-1.90

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$30M

Stock-Based Comp.

$21M

Balance Sheet

Total Assets

$408M

Total Liabilities

$257M

Stockholders' Equity

$150M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$116M	$71M	+63.6%
Gross Profit	$74M	$51M	+44.0%
Operating Income	-$52M	-$18M	-188.8%
Net Income	-$53M	-$16M	-233.9%